GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial shift in how we handle type 2 diabetes . These injectable medications function to mimicking the body’s natural GLP-1 https://wise-social.com/story7269850/glp-1-a-major-advance-in-diabetes-treatment